APA

Ossenkoppele G. J., Schuurhuis G. J., Jonkhoff A. R., van der Hem K. G., Legdeur M. C., Boot-Bakker A., Westra A. H., Dräger A. M. & Huijgens P. C. (19970218). High-dose melphalan with re-infusion of unprocessed, G-CSF-primed whole blood is effective and non-toxic therapy in multiple myeloma. : European journal of cancer (Oxford, England : 1990).

Chicago

Ossenkoppele G J, Schuurhuis G J, Jonkhoff A R, van der Hem K G, Legdeur M C, Boot-Bakker A, Westra A H, Dräger A M and Huijgens P C. 19970218. High-dose melphalan with re-infusion of unprocessed, G-CSF-primed whole blood is effective and non-toxic therapy in multiple myeloma. : European journal of cancer (Oxford, England : 1990).

Harvard

Ossenkoppele G. J., Schuurhuis G. J., Jonkhoff A. R., van der Hem K. G., Legdeur M. C., Boot-Bakker A., Westra A. H., Dräger A. M. and Huijgens P. C. (19970218). High-dose melphalan with re-infusion of unprocessed, G-CSF-primed whole blood is effective and non-toxic therapy in multiple myeloma. : European journal of cancer (Oxford, England : 1990).

MLA

Ossenkoppele G J, Schuurhuis G J, Jonkhoff A R, van der Hem K G, Legdeur M C, Boot-Bakker A, Westra A H, Dräger A M and Huijgens P C. High-dose melphalan with re-infusion of unprocessed, G-CSF-primed whole blood is effective and non-toxic therapy in multiple myeloma. : European journal of cancer (Oxford, England : 1990). 19970218.